Multi-Institutional Retrospective Study for the Efficacy of ICIs plus Platinum-Based Chemotherapy for EGFR Mutated NSCLC

被引：0
|
作者：
Kataoka, S. [1 ]
Miyawaki, T. [1 ]
Motojima, M. [2 ]
Shibayama, K. [1 ]
Nanba, Y. [2 ]
Mimori, T. [1 ]
Shukuya, T. [1 ]
Shimada, N. [1 ]
Koyama, R. [3 ]
Kido, K. [3 ]
Sasaki, S. [2 ]
Takahashi, K. [1 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Tokyo, Japan
[2] Juntendo Univ, Urayasu Hosp, Chiba, Japan
[3] Juntendo Univ, Nerima Hosp, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
EGFR mutated NSCLC; ICIs; retrospective study;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-04
引用
收藏
页码：S620 / S620
页数：1
相关论文
共 50 条
  • [21] Taxane-based versus platinum-based chemotherapy in early recurrent gastric cancer after radical surgery with S-1 adjuvant chemotherapy: A multi-institutional retrospective analysis
    Nagaoka, Sakae
    Yamashita, Hiroharu
    Seto, Yasuyuki
    Fujisaki, Muneharu
    Mitsumori, Norio
    Oshima, Yoko
    Yajima, Satoshi
    Kikuchi, Yoshinori
    Otsuka, Koji
    Murakami, Masahiko
    Fujita, Shohei
    Futawatari, Nobue
    Shimada, Hideaki
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (06) : 540 - 545
  • [22] Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials
    Zhou, Jian-Guo
    Tian, Xu
    Wang, Xue
    Tian, Jin-Hui
    Wang, Yi
    Wang, Fei
    Zhang, Yu
    Ma, Hu
    MEDICAL ONCOLOGY, 2015, 32 (02)
  • [23] DNA damage repair gene mutations predict the efficacy of platinum-based chemotherapy and immunotherapy plus platinum-based chemotherapy in advanced non-small cell lung cancer: a retrospective Chinese cohort study
    Xiao, Zhiwei
    Sun, Lingling
    Zheng, Yating
    Chen, Hanrui
    Zheng, Xinting
    Luo, Jiamin
    Gu, Chuying
    Lin, Ruiting
    Huang, Mengli
    Bai, Yuezong
    Chen, Zhe-Sheng
    Kinslow, Connor J.
    Loh, Jerold
    Lin, Lizhu
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (12) : 2539 - U159
  • [24] Treatment on advanced NSCLC: Platinum-based chemotherapy plus erlotinib or platinum-based chemotherapy alone? A systematic review and meta-analysis of randomised controlled trials
    Jian-Guo Zhou
    Xu Tian
    Xue Wang
    Jin-Hui Tian
    Yi Wang
    Fei Wang
    Yu Zhang
    Hu Ma
    Medical Oncology, 2015, 32
  • [25] Bone Metastases and Skeletal-Related Events in Patients with Metastatic NSCLC Treated with ICIs: A Multi-Institutional Study
    Qin, A.
    Zhao, S.
    Miah, A.
    Wei, L.
    Patel, S.
    Johns, A.
    Grogan, M.
    Bertino, E.
    He, K.
    Olugbile, S.
    Shields, P.
    Kalemkerian, G.
    Gadgeel, S.
    Ramnath, N.
    Schneider, B.
    Hassan, K.
    Carbone, D.
    Presley, C.
    Otterson, G.
    Owen, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S387 - S387
  • [26] A Multi-Institutional Retrospective Analysis of Oncologic Outcomes for Chinese Patients with Locally Advanced Cervical Cancer Undergoing Platinum-Based Adjuvant Chemotherapy after Concurrent Chemoradiotherapy
    Cheng, G.
    Wu, N.
    Su, X.
    Song, H.
    Li, Y.
    Gu, F.
    Sun, X.
    Li, X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E618 - E618
  • [27] Cetuximab plus platinum-based chemotherapy in head and neck cancer: A retrospective study in a single European Institution
    De Mello, R. A.
    Pantarotto Alves, M.
    Geros, S.
    Moreira, F.
    Vieira, C.
    Azevedo, I.
    Dinis, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S769 - S769
  • [28] First Line Sintilimab plus Anlotinib vs Platinum-based Chemotherapy in Metastatic NSCLC (SUNRISE): Updated Efficacy and Safety Analysis
    Chu, T.
    Han, B.
    Yu, Z.
    Wang, J.
    Zhao, Y.
    Mu, X.
    Yu, X.
    Shi, X.
    Shi, Q.
    Guan, M.
    Ding, C.
    Geng, N.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S616 - S616
  • [29] PHASE II STUDY OF S-1 PLUS IRINOTECAN FOR EGFR-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC) RESISTANT TO BOTH PLATINUM-BASED CHEMOTHERAPY AND EGFR-TKI: NJLCG0804
    Inoue, Akira
    Sugawara, Shunichi
    Harada, Masao
    Maemondo, Makoto
    Harada, Toshiyuki
    Kobayashi, Kunihiko
    Ishimoto, Osamu
    Fukumoto, Shinichi
    Matsubara, Nobumichi
    Okano, Tetsuya
    Nukiwa, Toshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S571 - S571
  • [30] Patritumab Deruxtecan (HER3-DXd) in EGFR-Mutated NSCLC Following EGFRTKI and Platinum-Based Chemotherapy: HERTHENA-Lung01
    Yu, H. A.
    Goto, Y.
    Hayashi, H.
    Felip, E.
    Yang, J. C. -H.
    Reck, M.
    Yoh, K.
    Lee, S. -H.
    Paz-Ares, L.
    Besse, B.
    Bironzo, P.
    Kim, D. -W.
    Johnson, M. L.
    Wu, Y. -L.
    Vigliotti, M.
    Dong, Q.
    Fan, P. -D.
    Shrestha, P.
    Sternberg, D. W.
    Sellami, D.
    Janne, P. A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S53 - S54
12345